These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 25835067

  • 1. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T, Puttipipatkhachorn S.
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [Abstract] [Full Text] [Related]

  • 2. Stabilizing ability of surfactant on physicochemical properties of drug nanoparticles generated from solid dispersions.
    Thongnopkoon T, Puttipipatkhachorn S.
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1082-1092. PubMed ID: 28161991
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR, Shelake MR, Shetty SS, Chavan-Patil AB, Pore YV, Late SG.
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF, Huang SJ, Zhu CL, Zhang SH, Zhang Q, Chen XJ, Liu QW.
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP, Patel MM.
    Pharm Dev Technol; 2007 Nov; 12(1):21-33. PubMed ID: 17484141
    [Abstract] [Full Text] [Related]

  • 10. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A.
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH, Patel HH, Donahue E, Patel AD.
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [Abstract] [Full Text] [Related]

  • 13. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ, Koolen SL, Huitema AD, Schellens JH, Beijnen JH, Nuijen B.
    Int J Pharm; 2011 Nov 28; 420(2):244-50. PubMed ID: 21907780
    [Abstract] [Full Text] [Related]

  • 14. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P, Kouwen S, Visser MR, Hinrichs WL, Frijlink HW.
    Pharm Dev Technol; 2010 Nov 28; 15(5):460-8. PubMed ID: 20735300
    [Abstract] [Full Text] [Related]

  • 15. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K, Yoo YJ.
    Drug Dev Ind Pharm; 2017 Sep 28; 43(9):1501-1509. PubMed ID: 28425323
    [Abstract] [Full Text] [Related]

  • 16. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
    Xu WJ, Liu Y, Shi LL, Cui JH, Cao QR.
    Pak J Pharm Sci; 2014 Nov 28; 27(6):1799-804. PubMed ID: 25362604
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J, Koolen S, Huitema A, Schellens J, Beijnen J, Nuijen B.
    Eur J Pharm Biopharm; 2013 Jan 28; 83(1):87-94. PubMed ID: 23085332
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
    Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ.
    Int J Nanomedicine; 2011 Jan 28; 6():2997-3009. PubMed ID: 22162657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.